trending Market Intelligence /marketintelligence/en/news-insights/trending/pqmsqslee40eu78r4fhcbw2 content esgSubNav
In This List

Philips receives US FDA clearance to market X-ray device

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Philips receives US FDA clearance to market X-ray device

The U.S. Food and Drug Administration granted Koninklijke Philips NV 510(k) clearance to market ProxiDiagnost N90, a digital radiography-fluoroscopy system.

Fluoroscopy is a kind of medical imaging in which a continuous X-ray image is shown on the monitor resembling a video of an X-ray.

Netherlands-based Koninklijke Philips operates as a health technology company, offering diagnostic imaging solutions, magnetic resonance imaging, computed tomography and diagnostic X-ray; advanced molecular imaging; integrated clinical solutions; and image-guided therapy solutions and therapy devices.